These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 20955461)

  • 21. Invasive Haemophilus influenzae type b disease in Sweden 1997-2003: epidemiological trends and patterns in the post-vaccine era.
    Farhoudi D; Löfdahl M; Giesecke J
    Scand J Infect Dis; 2005; 37(10):717-22. PubMed ID: 16191888
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunogenicity and safety of two doses of catch-up immunization with Haemophilus influenzae type b conjugate vaccine in Indian children living with HIV.
    Arya BK; Bhattacharya SD; Sutcliffe CG; Saha MK; Bhattacharyya S; Niyogi SK; Moss WJ; Panda S; Das RS; Mallick M; Mandal S
    Vaccine; 2016 Apr; 34(19):2267-74. PubMed ID: 26988256
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Haemophilus influenzae serotype B (Hib) seroprevalence in England and Wales in 2009.
    Ladhani S; Ramsay M; Flood J; Campbell H; Slack M; Pebody R; Findlow J; Newton E; Wilding M; Warrington R; Crawford H; Min S; Gray K; Martin S; Frankland S; Bokuvha N; Laher G; Borrow R
    Euro Surveill; 2012 Nov; 17(46):. PubMed ID: 23171823
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibody persistence and booster vaccination during the second and fifth years of life in a cohort of children who were born prematurely.
    Omeñaca F; Garcia-Sicilia J; Boceta R; Sistiaga-Hernando A; García-Corbeira P
    Pediatr Infect Dis J; 2007 Sep; 26(9):824-9. PubMed ID: 17721379
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibodies prevalence against Haemophilus influenzae type b in Jeddah population, Saudi Arabia. I. Total antibodies.
    Zarei AE; Redwan EM
    Hum Antibodies; 2018; 26(4):225-235. PubMed ID: 29945350
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Haemophilus influenzae type b (Hib) seroprevalence in France: impact of vaccination schedules.
    Hong E; Terrade A; Denizon M; Aouiti-Trabelsi M; Falguières M; Taha MK; Deghmane AE
    BMC Infect Dis; 2021 Jul; 21(1):715. PubMed ID: 34330228
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety and immunogenicity of two Haemophilus influenzae type b polysaccharide-tetanus toxoid conjugate vaccines (PRP-T) given with diphtheria-tetanus-pertussis vaccine to young Papua New Guinean children.
    Lehmann D; Kakazo M; Saleu G; Taime J; Javati A; Namuigi P; Alpers MP; Wegmüller B; Zellmeyer M; Fürer E; Que JU; Herzog C
    P N G Med J; 2001; 44(1-2):6-16. PubMed ID: 12418673
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibody response of Mexican infants to Haemophilus influenzae type b capsular polyribosylribitol phosphate. Differences between natural and vaccine induced (oligosaccharide-CRM197 conjugated vaccine) immunization.
    Massó F; Paéz A; Arista A; Salmón L; Montaño L
    Arch Med Res; 1996; 27(4):539-45. PubMed ID: 8987192
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term immunological follow-up of children with haemophilus influenzae serotype b vaccine failure in the United Kingdom.
    Ladhani S; Heath PT; Ramsay ME; Slack MP; Kibwana E; Pollard AJ; Booy R
    Clin Infect Dis; 2009 Aug; 49(3):372-80. PubMed ID: 19580418
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunogenicity of routinely used childhood vaccines when coadministered with the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV).
    Knuf M; Szenborn L; Moro M; Petit C; Bermal N; Bernard L; Dieussaert I; Schuerman L
    Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S97-S108. PubMed ID: 19325452
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunological characterization of conjugated Haemophilus influenzae type b vaccine failure in infants.
    Breukels MA; Spanjaard L; Sanders LA; Rijkers GT
    Clin Infect Dis; 2001 Jun; 32(12):1700-5. PubMed ID: 11360210
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dose response of CRM197 and tetanus toxoid-conjugated Haemophilus influenzae type b vaccines.
    Huebner RE; Nicol M; Mothupi R; Käyhty H; Mbelle N; Khomo E; Klugman KP
    Vaccine; 2004 Dec; 23(6):802-6. PubMed ID: 15542205
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Haemophilus influenzae type b (Hib) seroprevalence and current epidemiology in England and Wales.
    Collins S; Litt D; Almond R; Findlow J; Linley E; Ramsay M; Borrow R; Ladhani S
    J Infect; 2018 Apr; 76(4):335-341. PubMed ID: 29289561
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fall in Haemophilus influenzae serotype b (Hib) disease following implementation of a booster campaign.
    Ladhani S; Slack MP; Heys M; White J; Ramsay ME
    Arch Dis Child; 2008 Aug; 93(8):665-9. PubMed ID: 17942585
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Utilization pattern of Haemophilus influenza type b vaccine in eight provinces of China.
    Li Y; Yue C; Wang Y; Zhu X; Martin K; Scherpbier RW; Liu J; Wang Z; Ma Y; Cheng H; Zhang Z; Wang Q; Li H; Xie S; Xiao Q; Wang H; An Z
    Hum Vaccin Immunother; 2018 Apr; 14(4):894-899. PubMed ID: 29300680
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunogenicity of Haemophilus b conjugate vaccine (meningococcal protein conjugate) in children with prior invasive Haemophilus influenzae type b disease.
    Walter EB; Moggio MV; Drucker RP; Wilfert CM
    Pediatr Infect Dis J; 1990 Sep; 9(9):632-5. PubMed ID: 2235187
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Booster immunization with a hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated poliovirus vaccine and Haemophilus influenzae type b conjugate combination vaccine in the second year of life: safety, immunogenicity and persistence of antibody responses.
    Heininger U; ; ; Sänger R; Jacquet JM; Schuerman L
    Vaccine; 2007 Jan; 25(6):1055-63. PubMed ID: 17049692
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Continued shortage of Haemophilus influenzae Type b (Hib) conjugate vaccines and potential implications for Hib surveillance--United States, 2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Nov; 57(46):1252-5. PubMed ID: 19023262
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Haemophilus influenzae type b reemergence after combination immunization.
    Johnson NG; Ruggeberg JU; Balfour GF; Lee YC; Liddy H; Irving D; Sheldon J; Slack MP; Pollard AJ; Heath PT
    Emerg Infect Dis; 2006 Jun; 12(6):937-41. PubMed ID: 16707049
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Two decades of experience with the Haemophilus influenzae serotype b conjugate vaccine in the United Kingdom.
    Ladhani SN
    Clin Ther; 2012 Feb; 34(2):385-99. PubMed ID: 22244051
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.